Unlock instant, AI-driven research and patent intelligence for your innovation.

Targeted ubiquitination TRK degradation compound and preparation method, composition and application thereof

A compound and alkyl technology, applied in the field of compounds targeting ubiquitination to degrade TRK, can solve problems such as drug resistance, drug resistance, and off-target

Active Publication Date: 2022-08-05
北京鑫开元医药科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at present, these two TRK inhibitors also have the problem of drug resistance. Once drug resistance occurs, it is necessary to replace the drug immediately to solve the problem of drug resistance and off-target. In order to achieve better tumor treatment effect, with better To meet the clinical and market needs, the development of safer and more efficient new TRK inhibitor drugs has huge social value and economic benefits

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted ubiquitination TRK degradation compound and preparation method, composition and application thereof
  • Targeted ubiquitination TRK degradation compound and preparation method, composition and application thereof
  • Targeted ubiquitination TRK degradation compound and preparation method, composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0079] In a second aspect, an embodiment of the present invention provides a method for preparing the compound or a pharmaceutically acceptable salt thereof as described in the first aspect, comprising the following steps:

[0080] S1.

[0081] Compound II is reacted with pinacol biboronate in a first reaction solvent in the presence of a first base under the action of a first catalyst to obtain intermediate III;

[0082] S2.

[0083] The intermediate III and compound IV are reacted in a second reaction solvent in the presence of a second base under the action of a second catalyst to obtain intermediate V;

[0084] S3. When the compound or a pharmaceutically acceptable salt thereof has the structure of formula I-a:

[0085]

[0086] The intermediate V and the compound having the structure of formula VI are reacted in the third reaction solvent in the presence of the third base to obtain the intermediate having the structure of formula VII;

[0087]When the compound o...

Embodiment 1

[0118] Preparation of Example 1 Compound 1

[0119]

[0120]

[0121]

[0122] Synthesis of S1, intermediate a2:

[0123] Compound a1 (5.0 g, 23.58 mmol), pinacol diboronate (7.2 g, 28.3 mmol) and potassium acetate (4.6 g, 47.00 mmol) were dissolved in 1,4-dioxane (50 mL) and stirred Disperse, add Pd(dppf)Cl 2 ([1,1'-bis(diphenylphosphino)ferrocene]palladium dichloride, 1.7g, 2.36mmol), replaced with nitrogen three times, heated to 100°C, reacted for 4 hours, monitored by TLC, the reaction was complete After that, it was cooled to room temperature, filtered, and the filter cake was discarded. The filtrate was collected, and the filtrate was concentrated to dryness under reduced pressure to obtain a concentrated residue. To the concentrated residue, ethyl acetate was added until it was completely dissolved, washed twice with water, and saturated with sodium chloride. The aqueous solution was washed once, the organic phase was dried over anhydrous sodium sulfate, and ...

Embodiment 2

[0138] Preparation of Example 2 Compound 2

[0139]

[0140] Synthesis of S1, intermediate b6:

[0141] Intermediate a4 (2.1 g, 8.10 mmol) and compound b5 (1.6 g, 9.72 mmol) were dissolved in absolute ethanol (100 mL), piperidine (63 drops) was added at room temperature, and the temperature was raised to 85 °C for 4 hours. TLC The reaction was monitored. After the reaction was completed, it was lowered to room temperature, filtered, and the filter cake was washed with 30 mL of n-heptane, dried by suction, and dried in vacuo to obtain 2.6 g of intermediate b6, which was a yellow solid with a yield of 78.6%.

[0142] Synthesis of S2, intermediate b7:

[0143] Intermediate b6 (2.6 g, 6.37 mmol) was dissolved in methanol (81 mL), 2 mol / L aqueous sodium hydroxide solution (27 mL) was added, the temperature was raised to 65 °C for 7 hours, and the reaction was monitored by TLC. After the reaction was completed, it was lowered to room temperature, Concentrate under reduced press...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, and particularly relates to a compound for degrading TRK through targeted ubiquitination as well as a preparation method, a composition and application of the compound. R1 and R2 represent hydrogen, fluorine, chlorine, bromine, iodine, an unsubstituted C1-4 alkyl group, a substituted C1-4 alkyl group, an unsubstituted C1-4 alkoxy group, a substituted C1-4 alkoxy group, an unsubstituted C1-4 alkylthio group, a substituted C1-4 alkylthio group, an unsubstituted C1-4 alkylamino group or a substituted C1-4 alkylamino group; m represents carbon, nitrogen, oxygen or sulfur; q1, Q2 and Q3 represent carbon or nitrogen; w1 represents carbon or nitrogen; r3 represents hydrogen, fluorine, chlorine, bromine, iodine, an aldehyde group, a carboxyl group, a hydroxyl group, an amino group, a sulfydryl group, an unsubstituted C1-4 alkyl group, a substituted C1-4 alkyl group, or; l represents; d represents, or the like. The compound provided by the invention can realize TRK induced degradation.

Description

technical field [0001] The invention belongs to the field of medicine, and particularly relates to a compound targeting ubiquitination to degrade TRK and its preparation method, composition and use. Background technique [0002] Tropomyosin-receptor kinase (TRK, also known as "tropomyosin receptor kinase") is a class of neurotrophin receptors belonging to the receptor tyrosine kinase family, including TRKA, TRKB and TRKC 3 isoforms, which are encoded by NTRK1 (neurotrophic receptor tyrosine kinase 1), NTRK2 and NTRK3 genes respectively. When the NTRK gene is fused with other genes, it can induce receptor dimerization and phosphorylation, resulting in high expression of TRK or continuous increase in TRK activity, and activation of downstream PI3K / Akt / mTOR, PLCγ and Ras / Raf / MEK / ERK signaling cascade, thereby regulating tumor cell growth, proliferation, invasion, migration, angiogenesis and drug resistance. [0003] The first-generation TRK inhibitors, Larotrectinib and Entr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D401/14A61P35/00A61K31/4439A61K31/4545
CPCC07D401/14A61P35/00
Inventor 蒋兴凯王岩范伏田汪小涧潘显道毕续海马明阳苏小庭戴信敏
Owner 北京鑫开元医药科技有限公司